Intermittent cyclical etidronate therapy for the prevention of rheumatoid arthritis induced bone loss following 18 months of fluoride therapy or placebo. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • August 1, 1997